JACC: Cardiooncology

Papers
(The H4-Index of JACC: Cardiooncology is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Full Issue PDF126
Editorial Board120
Full Issue PDF109
Full Issue PDF98
Priorities in Cardio-Oncology96
Balancing Promise and Evidence72
Hormonal Therapy and Cardiovascular Health71
To Anticoagulate or Not to Anticoagulate to Prevent Arterial Thrombosis During Systemic Cancer Therapy69
Atrial Fibrillation in Patients With Cancer68
Full Issue PDF68
Prospective Screening for Transthyretin Cardiac Amyloidosis in Spinal Stenosis Surgery Patients62
Epigenomics of Cardio-Oncology59
Cardiovascular Safety in Oncology Clinical Trials58
LAG3 Blockade Expands T Cells Within Atherosclerotic Plaque56
Cancer Therapy and Exercise Intolerance: The Heart Is But a Part55
SGLT2i and Primary Prevention of Cancer Therapy–Related Cardiac Dysfunction in Patients With Diabetes55
Deep Inspiration Breath Hold in Left-Sided Breast Radiotherapy53
Cardiac Risk Stratification Before Lung Cancer Radiation51
Rivaroxaban Efficacy and Safety in SELECT-D Community Cancer-Associated Venous Thromboembolism Patients50
Moving the Pendulum for Earlier Detection of Systolic and Diastolic Dysfunction in Cancer Survivors49
Full Issue PDF46
Assessing Neurohormonal Antagonist Withdrawal in HER2+ Breast Cancer Patients With CTRCD45
Novel Technologies Must Be Considered for Childhood Cancer Survivors at Risk for Cardiomyopathy43
CARDIAC, MUSCULAR, AND NEUROLOGICAL TOXICITY SECONDARY TO PEMBROLIZUMAB IN A PATIENT WITH MELANOMA40
Long-Term, Implantable Event Monitoring of Patients With Wild-Type Transthyretin Cardiac Amyloidosis38
Beyond Thrombosis: Pulmonary Hypertension and Heart Failure in Patients With Myeloproliferative Neoplasms38
Common Pathophysiology in Cancer, Atrial Fibrillation, Atherosclerosis, and Thrombosis37
Frailty37
Prevalence, Treatment, and Prognosis of Tumor Thrombi in Renal Cell Carcinoma35
Cardiac Substructure Radiation Dose and Associations With Tachyarrhythmia and Bradyarrhythmia After Lung Cancer Radiotherapy34
PROPORTIONATE AND ABSOLUTE PULMONARY EMBOLISM MORTALITY IN ONCOLOGY IN THE UNITED STATES FROM 1999-201931
Atorvastatin Does Not Attenuate Aortic Stiffening After Doxorubicin for Breast Cancer and Lymphoma (PREVENT-WF-98213)31
Editorial Board/Officers Page31
0.12889695167542